Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2007

Dowpharma Licenses Pfenex Expression Technology to Biovel Life Sciences

  • Dowpharma  licensed its Pfenex Expression Technology™ to India-based Biovel Life Sciences. The agreement grants Biovel rights to employ the Pseudomonas fluorescense-based technology for the production of human growth hormone (HGH), a biosimilar product. 

    Dowpharma says it has already developed a high-yield production strain and process for the production of HGH and will prepare and transfer to Biovel a research cell bank and the production process. The agreement provides for an upfront technology access fee, maintenance and milestone fees, as well as royalties on product sales.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »